文献速递生殖医学

基于靶向二代测序的综合染色体筛查平台检测人类囊胚三倍体的验证

Validation of a targeted next generation sequencing-based comprehensive chromosome screening platform for detection of triploidy in human blastocysts.
PubMed 文献 · Reprod Biomed Online · 2018-01-02

本研究验证了基于靶向二代测序(tNGS)的综合染色体筛查平台检测人类囊胚三倍体的能力、频率及亲本来源。第一阶段盲法对照样本的核型和倍性均被正确预测;第二阶段在18,791枚囊胚中三倍体频率为0.474%(89/18,791);第三阶段5枚有亲本DNA的可疑三倍体囊胚被确认三倍体且来源为母源。

要点

  • tNGS平台可准确检测滋养外胚层活检中的三倍体。
  • 18,791枚囊胚中三倍体频率为0.474%(89/18,791)。
  • 胞浆内单精子注射来源囊胚的三倍体罕见且多为母源。

核心结论

  • tNGS提供比其他当代NGS平台更高的测序深度,可准确调用单核苷酸多态性并准确检测滋养外胚层活检中的三倍体。
  • 胞浆内单精子注射来源囊胚的三倍体罕见且多为母源。

研究设计与样本

  • 研究分三阶段:第一阶段对二倍体和三倍体对照样本进行盲法tNGS测序并比较核型预测准确性;第二阶段用tNGS计算18,791枚人类囊胚滋养外胚层活检的三倍体频率;第三阶段对亲本gDNA测序评估遗传额外等位基因的亲本来源以验证第二阶段的三倍体预测。

主要发现

  • 第一阶段所有对照的核型和倍性均被两种独立方法正确预测。
  • 第二阶段囊胚三倍体频率为0.474%(89/18,791)。
  • 第三阶段5枚有亲本DNA的可疑三倍体囊胚被确认三倍体且为母源。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Triploidy accounts for ~2% of natural pregnancies and 15% of cytogenetically abnormal miscarriages. This study aimed to validate triploidy detection in human blastocysts, its frequency and parental origin using genotyping data generated in parallel with chromosome copy number analysis by a targeted next generation sequencing (tNGS)-based comprehensive chromosome screening platform. Phase 1: diploid and triploid control samples were blinded, sequenced by tNGS and karyotype predictions compared for accuracy. Phase 2: tNGS was used to calculate the frequency of triploidy in 18,791 human blastocysts from trophectoderm (TE) biopsies. Phase 3: parental origin of the inherited extra alleles was evaluated by sequencing parental gDNA to validate triploidy predictions from Phase 2. All karyotypes and ploidy in controls from Phase 1 were correctly predicted by two independent methods. A blastocyst triploidy frequency of 0.474% (89/18,791) was observed in Phase 2 of the study. Finally, five suspected triploid blastocysts with parental DNA available were confirmed to be triploid and of maternal origin. tNGS provides higher sequencing depth in contrast to other contemporary NGS platforms, allowing for accurate single nucleotide polymorphism calling and accurate detection of triploidy in TE biopsies. Triploidy in intracytoplasmic sperm injection-derived blastocysts is rare and mostly of maternal origin.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Marin D, Zimmerman R, Tao X, et al. Validation of a targeted next generation sequencing-based comprehensive chromosome screening platform for detection of triploidy in human blastocysts. Reprod Biomed Online. 2018. PMID: 29366772. doi:10.1016/j.rbmo.2017.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。